Michelle Fan-Port

Michelle Fan-Port is currently the VP Translational Biometrics at ArsenalBio. Prior to this role, Michelle worked as a Sr Director at A2 Biotherapeutics, Inc and held various positions at Amgen from 2003 to 2019, including Director of Biostatistics and Biostatistics Sr Manager. Michelle began their career as a Biostatistician at Eli Lilly and Company. Michelle holds a PhD in Biostatistics, a BS, and an MS from the University of Toronto.